The Latest Breaking News from Pfizer

Paxlovid goes from COVID game-changer to pandemic enigma

The CDC recommends the new Pfizer-BioNTech booster for individuals 12 years and the Moderna vaccine for individuals 18 and up.

The stock market has been down following Fed Chair Jerome Powell’s Jackson Hole speech that signaled continued monetary policy tightening. We think in this current volatile backdrop, people planning their retirement savings in their 30s should invest in fundamentally sound dividend-paying stocks Pfizer (PFE) and Costco (COST). Read more….

Government advisers are debating who should should get new updated COVID-19 boosters and when

The European Union’s drug regulator has recommended the use of two Omicron-tailored vaccines developed by the Pfizer-BioNTech partnership and Moderna Inc ahead of a fresh booster programme this fall across the continent.

On Sept. 1, 2022, the Centers for Disease Control and Prevention endorsed the use of updated COVID-19 booster shots that are specifically tailored to combat the two most prevalent omicron subvariants, BA.4 and BA.5. The decision comes just a day after the Food and Drug Administration’s emergency use authorization of…

The FDA today authorized the new booster, which could arrive as early as next week in Chicago, where nearly 2 million residents are expected to be eligible.

Last week, the FDA authorized both Pfizer and Moderna's Omicron-specific jabs. Experts say to get them as soon as they are available to you.

COVID-19 boosters from Moderna Inc. and the partnership of Pfizer Inc. and BioNTech SE that are tailored to the latest COVID-19 omicron variants got U.S. regulatory clearance, a move toward additional protection as concern grows about potential new waves in the fall and winter.